Live Breaking News & Updates on Pearsanta Inc|Page 2

Stay updated with breaking news from Pearsanta inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028

/PRNewswire/ DelveInsight s Liquid Biopsy in Cancer Diagnostics Market Insights report provides the current and forecast market analysis, individual leading. ....

United States , Shruti Thakur , Prnewswire Delveinsight , B Braun Melsungen , Exai Bio , Daiichi Sankyo , Cardinal Health , Angle Plc , Agilent Technologies Inc , Menarini Group , Boston Scientific Corporation , Abbvie Inc , Market Research , Genetics Inc , Hologic Inc , National Coverage , Sysmex Ionostics Inc , Foundation Medicine Inc , Olympus Corporation , Illumina Inc , Thermo Fisher Scientific Inc , Idera Pharmaceuticals , Lucence Health Inc , Gemone Diagnostics Inc , F Hoffman La Roche Ltd , Life Sciences Inc ,

Aditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million -January 08, 2024 at 08:37 am EST

This strategic acquisition positions Pearsanta for robust growth: expanding opportunities in women’s health, spanning endometriosis to ovarian cancer, and in men’s health starting with prostate. ....

United States , Chris Mitton , Amro Albanna , Ernie Lee , Exchange Commission , Life Sciences Inc , American Cancer Society , Evofem Biosciences Inc , Pearsanta Inc , Aditxt Inc , World Health Organization , Precision Medicine , Mitomic Endometriosis Test , Mitomic Prostate Test , Vast Opportunities , Early Cancer , Fortune Business Inside , Evofem Biosciences , Current Report , Asset Purchase , Annual Report ,

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc.'s Mitomic(TM) Testing Platform

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX), Subsidiary Pearsanta Announce Acquisition of MDNA Life Sciences Inc.'s Mitomic(TM) Testing Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ernie Lee , Los Angeles , Aditxt Inc , Pearsanta Inc , Adimune Tm Inc , Pearsanta Tm Inc , Life Sciences Inc , Adivir Tm Inc , Mitomic Endometriosis Test , Mitomic Prostate Test , Dynamic Brand Portfolio ,

Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt, Inc. , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has closed its previously. ....

United States , Hc Wainwright Co , Pearsanta Inc , Aditxt Inc , Adivir Inc , Adimune Inc , Exchange Commission , Securities Act , Promising Innovations Possible , Annual Report ,

Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules

Aditxt Announces $6 Million Private Placement Priced At-The-Market under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Exchange Commission , Aditxt Inc , Adimune Inc , Hc Wainwright Co , Adivir Inc , Pearsanta Inc , Securities Act , Promising Innovations Possible , Annual Report ,